World's Best Scientists 2026 revealed!
Norbert Weissmann

Norbert Weissmann

D-Index & Metrics

Medicine

D-Index
97
Citations
33906
World Ranking
9304
National Ranking
515

Overview

Norbert Weissmann is affiliated with the University of Giessen in Germany and has a research focus on pulmonary and respiratory medicine within the broader fields of medicine, biochemistry, genetics, and molecular biology.

The scientist's research covers several primary topics including:

  • Pulmonary Hypertension Research and Treatments
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory Support and Mechanisms
  • Neonatal Respiratory Health Research
  • Mitochondrial Function and Pathology
  • Neuroscience of Respiration and Sleep
  • Nitric Oxide and Endothelin Effects

In terms of publication venues, Norbert Weissmann frequently publishes in:

  • American Journal of Respiratory and Critical Care Medicine
  • Pneumologie
  • Circulation
  • International Journal of Molecular Sciences
  • American Journal of Respiratory Cell and Molecular Biology

Noteworthy recent papers include:

  • "Hypoxia-inducible factor signaling in pulmonary hypertension," 2020, Journal of Clinical Investigation
  • "Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders," 2021, International Journal of Environmental Research and Public Health
  • "Pulmonary Hypertension: A Contemporary Review," 2023, American Journal of Respiratory and Critical Care Medicine
  • "Acute O 2 sensing through HIF2α-dependent expression of atypical cytochrome oxidase subunits in arterial chemoreceptors," 2020, Science Signaling
  • "Pulmonary hypertension in chronic obstructive pulmonary disease," 2020, British Journal of Pharmacology

Frequent co-authors associated with Norbert Weissmann include:

  • Werner Seeger
  • Ralph T. Schermuly
  • Natascha Sommer
  • Hossein Ardeschir Ghofrani
  • Oleg Pak

Best Publications

  • Reversal of experimental pulmonary hypertension by PDGF inhibition.

    Ralph Theo Schermuly;Eva Dony;Hossein Ardeschir Ghofrani;Soni Pullamsetti

  • Cellular and molecular basis of pulmonary arterial hypertension.

    Nicholas W. Morrell;Serge Adnot;Stephen L. Archer;Jocelyn Dupuis

  • Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

    Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Ralph T Schermuly

  • Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase.

    Nermin Kuzkaya;Norbert Weissmann;David G. Harrison;Sergey Dikalov

  • Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension

    Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Horst Olschewski

  • Nox family NADPH oxidases: Molecular mechanisms of activation

    Ralf P. Brandes;Norbert Weissmann;Katrin Schröder

  • Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase

    Katrin Schröder;Min Zhang;Sebastian Benkhoff;Anja Mieth

  • Pulmonary hypertension in chronic lung disease and hypoxia.

    Steven D. Nathan;Joan A. Barbera;Sean P. Gaine;Sergio Harari

  • Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

    Hossein A Ghofrani;Frank Rose;Ralph T Schermuly;Horst Olschewski

  • Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.

    Christoph Kleinschnitz;Henrike Grund;Kirstin Wingler;Melanie Elise Armitage

  • Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.

    Hossein A. Ghofrani;Robert Voswinckel;Frank Reichenberger;Horst Olschewski

  • Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension.

    Rajkumar Savai;Soni S. Pullamsetti;Julia Kolbe;Ewa Bieniek

  • Sildenafil for Long-Term Treatment of Nonoperable Chronic Thromboembolic Pulmonary Hypertension

    Hossein A. Ghofrani;Ralph T. Schermuly;Frank Rose;Ralph Wiedemann

  • Inducible NOS Inhibition Reverses Tobacco-Smoke-Induced Emphysema and Pulmonary Hypertension in Mice

    Michael Seimetz;Nirmal Parajuli;Alexandra Pichl;Florian Veit

  • Hypoxia-Dependent Regulation of Nonphagocytic NADPH Oxidase Subunit NOX4 in the Pulmonary Vasculature

    Manish Mittal;Markus Roth;Peter König;Simone Hofmann

  • Chronic Sildenafil Treatment Inhibits Monocrotaline-induced Pulmonary Hypertension in Rats

    Ralph T. Schermuly;Klaus P. Kreisselmeier;Hossein A. Ghofrani;Hüseyin Yilmaz

  • NADPH oxidases in cardiovascular disease.

    Ralf P. Brandes;Norbert Weissmann;Katrin Schröder

  • Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange.

    Norbert Weissmann;Alexander Dietrich;Beate Fuchs;Hermann Kalwa

  • The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups

    Henning Gall;Janine F. Felix;Franziska K. Schneck;Katrin Milger

  • First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension.

    F. Grimminger;G. Weimann;R. Frey;R. Voswinckel

Frequent Co-Authors

Werner Seeger
Werner Seeger University of Giessen
Ralph T. Schermuly
Ralph T. Schermuly University of Giessen
Friedrich Grimminger
Friedrich Grimminger University of Giessen
Hossein Ardeschir Ghofrani
Hossein Ardeschir Ghofrani University of Giessen
Ralf P. Brandes
Ralf P. Brandes Goethe University Frankfurt
Horst Olschewski
Horst Olschewski Medical University of Graz
Alexander Dietrich
Alexander Dietrich Ludwig-Maximilians-Universität München
Martin Witzenrath
Martin Witzenrath Charité - University Medicine Berlin
Thomas Gudermann
Thomas Gudermann Ludwig-Maximilians-Universität München
Walter Klepetko
Walter Klepetko Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of Medicine in the USA opens doors to numerous online degrees and career pathways, ideal for those seeking flexibility alongside academic advancement. Many professionals consider pursuing cahme accredited online mha programs to build strong leadership skills in healthcare administration.

For nurses looking to expand their qualifications, there are pathways such as an rn to bsn without clinicals, which offers greater convenience for working professionals. Those aiming to advance to the highest levels of nursing may consider accelerated msn to dnp programs, allowing quicker completion of this terminal degree.

Affordability is also a key concern for students. Options like affordable dnp programs ensure you can reach your career goals without incurring overwhelming costs. These diverse online programs provide accessible routes to both clinical and administrative roles within the healthcare system.

Best Scientists Citing Norbert Weissmann

Trending Scientists